Works matching IS 13518216 AND DT 2023 AND VI 29 AND IP 1
Results: 54
Hypertension in haemophilia: A meta‐analysis.
- Published in:
- Haemophilia, 2023, v. 29, n. 1, p. 352, doi. 10.1111/hae.14686
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Haemophilia, 2023, v. 29, n. 1, p. i, doi. 10.1111/hae.14732
- Publication type:
- Article
Treatment of haematuria with factor concentrate in people with haemophilia is associated with low rates of complications.
- Published in:
- Haemophilia, 2023, v. 29, n. 1, p. 401, doi. 10.1111/hae.14726
- By:
- Publication type:
- Article
Clinical outcomes of low‐dose pharmacokinetic‐guided extended half‐life versus low‐dose standard half‐life factor VIII concentrate prophylaxis in haemophilia A patients.
- Published in:
- Haemophilia, 2023, v. 29, n. 1, p. 156, doi. 10.1111/hae.14700
- By:
- Publication type:
- Article
A decreased and less sustained response to surrogates of haemostatic stress correlates with bleeding in type 1 von Willebrand disease.
- Published in:
- Haemophilia, 2023, v. 29, n. 1, p. 370, doi. 10.1111/hae.14699
- By:
- Publication type:
- Article
Pharmacokinetic parameters of recombinant factor IX Fc fusion protein are not influenced by factor IX antigen levels in subjects from the Phase 3 B‐LONG trial.
- Published in:
- Haemophilia, 2023, v. 29, n. 1, p. 404, doi. 10.1111/hae.14727
- By:
- Publication type:
- Article
Switching to emicizumab: A prospective surveillance study in haemophilia A subjects with inhibitors.
- Published in:
- Haemophilia, 2023, v. 29, n. 1, p. 348, doi. 10.1111/hae.14685
- By:
- Publication type:
- Article
Safety of FEIBA and emicizumab (SAFE): Dose escalation study evaluating the safety of in vivo administration of activated prothrombin complex concentrate in haemophilia A patients on emicizumab.
- Published in:
- Haemophilia, 2023, v. 29, n. 1, p. 100, doi. 10.1111/hae.14684
- By:
- Publication type:
- Article
Early changes in bleeding perception and quality of life in children and adolescents receiving emicizumab prophylaxis for severe haemophilia A without inhibitor.
- Published in:
- Haemophilia, 2023, v. 29, n. 1, p. 397, doi. 10.1111/hae.14724
- By:
- Publication type:
- Article
Impact of COVID‐19 on professionals and patients in haemophilia care – The perspective from the EAHAD Psychosocial Working Group.
- Published in:
- Haemophilia, 2023, v. 29, n. 1, p. 394, doi. 10.1111/hae.14721
- By:
- Publication type:
- Article
Burden on parents of children with moderate or severe von Willebrand disease: The impact of clinical data.
- Published in:
- Haemophilia, 2023, v. 29, n. 1, p. 390, doi. 10.1111/hae.14718
- By:
- Publication type:
- Article
Chronic pain in patients with hemophilia: Influence of kinesiophobia and catastrophizing thoughts.
- Published in:
- Haemophilia, 2023, v. 29, n. 1, p. 386, doi. 10.1111/hae.14708
- By:
- Publication type:
- Article
Effectiveness of monthly low dose emicizumab prophylaxis without 4‐week loading doses among patients with haemophilia A with and without inhibitors: A case series report.
- Published in:
- Haemophilia, 2023, v. 29, n. 1, p. 382, doi. 10.1111/hae.14707
- By:
- Publication type:
- Article
Gene therapy preferences and informed decision‐making: Results from a National Hemophilia Foundation Community Voices in research survey.
- Published in:
- Haemophilia, 2023, v. 29, n. 1, p. 51, doi. 10.1111/hae.14706
- By:
- Publication type:
- Article
ACTIVLIM‐Hemo: A new self‐reported, unidimensional and linear measure of activity limitations in persons with haemophilia.
- Published in:
- Haemophilia, 2023, v. 29, n. 1, p. 317, doi. 10.1111/hae.14705
- By:
- Publication type:
- Article
Real‐world prophylactic usage of recombinant factor IX Fc in Sweden: A report from the Swedish National Registry for bleeding disorders.
- Published in:
- Haemophilia, 2023, v. 29, n. 1, p. 377, doi. 10.1111/hae.14704
- By:
- Publication type:
- Article
Emicizumab assays evaluations with four different reagents in severe haemophilia A patients: Concentration from baseline to maintenance therapy.
- Published in:
- Haemophilia, 2023, v. 29, n. 1, p. 374, doi. 10.1111/hae.14703
- By:
- Publication type:
- Article
Activity and participation in haemophiliacs: Item response modelling based on international classification of functioning, disability and health.
- Published in:
- Haemophilia, 2023, v. 29, n. 1, p. 308, doi. 10.1111/hae.14702
- By:
- Publication type:
- Article
Improving bleeding disorder treatment log adherence: An application of the information‐motivation‐behavioral skills model.
- Published in:
- Haemophilia, 2023, v. 29, n. 1, p. 180, doi. 10.1111/hae.14701
- By:
- Publication type:
- Article
180‐degree immersive VR motion visualization in the treatment of haemophilic ankle arthropathy.
- Published in:
- Haemophilia, 2023, v. 29, n. 1, p. 282, doi. 10.1111/hae.14683
- By:
- Publication type:
- Article
Life‐threatening complication of central venous catheter in a child with severe haemophilia A.
- Published in:
- Haemophilia, 2023, v. 29, n. 1, p. 367, doi. 10.1111/hae.14697
- By:
- Publication type:
- Article
Occurrence of familial Mediterranean fever in haemophilia patients.
- Published in:
- Haemophilia, 2023, v. 29, n. 1, p. 165, doi. 10.1111/hae.14698
- By:
- Publication type:
- Article
The detrimental effects of iron to the joint; aggravation by inflammation.
- Published in:
- Haemophilia, 2023, v. 29, n. 1, p. 365, doi. 10.1111/hae.14696
- By:
- Publication type:
- Article
Relationship between serum cartilage turnover biomarkers and haemophilic arthropathy severity in adult patients with severe haemophilia A in China.
- Published in:
- Haemophilia, 2023, v. 29, n. 1, p. 362, doi. 10.1111/hae.14695
- By:
- Publication type:
- Article
Harmonizing patient‐reported outcome measurements in inherited bleeding disorders with PROMIS.
- Published in:
- Haemophilia, 2023, v. 29, n. 1, p. 357, doi. 10.1111/hae.14694
- By:
- Publication type:
- Article
Haemophilia A and B – evaluation of the Swedish prophylactic regimen by magnetic resonance imaging.
- Published in:
- Haemophilia, 2023, v. 29, n. 1, p. 193, doi. 10.1111/hae.14693
- By:
- Publication type:
- Article
Drug‐associated acquired hemophilia A: an analysis based on 185 cases from the WHO pharmacovigilance database.
- Published in:
- Haemophilia, 2023, v. 29, n. 1, p. 186, doi. 10.1111/hae.14692
- By:
- Publication type:
- Article
Area under the curve: Comparing the value of factor VIII replacement therapies in haemophilia A.
- Published in:
- Haemophilia, 2023, v. 29, n. 1, p. 145, doi. 10.1111/hae.14691
- By:
- Publication type:
- Article
Proof of concept and feasibility of a blended physiotherapy intervention for persons with haemophilic arthropathy.
- Published in:
- Haemophilia, 2023, v. 29, n. 1, p. 290, doi. 10.1111/hae.14690
- By:
- Publication type:
- Article
IDEAL study: A real‐world assessment of pattern of use and clinical outcomes with recombinant coagulation factor IX albumin fusion protein (rIX‐FP) in patients with haemophilia B in Italy.
- Published in:
- Haemophilia, 2023, v. 29, n. 1, p. 135, doi. 10.1111/hae.14689
- By:
- Publication type:
- Article
Pregnancy and childbirth in women with bleeding disorders: A retrospective cohort study.
- Published in:
- Haemophilia, 2023, v. 29, n. 1, p. 240, doi. 10.1111/hae.14688
- By:
- Publication type:
- Article
Diminished cortical bone density of long bones among children with haemophilic arthropathy.
- Published in:
- Haemophilia, 2023, v. 29, n. 1, p. 274, doi. 10.1111/hae.14682
- By:
- Publication type:
- Article
Emicizumab dose up‐titration in case of suboptimal bleeding control in people with haemophilia A.
- Published in:
- Haemophilia, 2023, v. 29, n. 1, p. 90, doi. 10.1111/hae.14679
- By:
- Publication type:
- Article
How to assess, detect, and manage joint involvement in the era of transformational therapies: Role of point‐of‐care ultrasound.
- Published in:
- Haemophilia, 2023, v. 29, n. 1, p. 1, doi. 10.1111/hae.14657
- By:
- Publication type:
- Article
Physical activity, physical fitness and cardiometabolic risk amongst adults with moderate and severe haemophilia.
- Published in:
- Haemophilia, 2023, v. 29, n. 1, p. 72, doi. 10.1111/hae.14653
- By:
- Publication type:
- Article
Increased acute care utilisation, comorbidities and mortality in adults with haemophilia: A population‐based cohort study from 2012 to 2019.
- Published in:
- Haemophilia, 2023, v. 29, n. 1, p. 219, doi. 10.1111/hae.14680
- By:
- Publication type:
- Article
The effect of a virtual child disease management programme on burden and social adjustment of caregivers of children with coagulation factor deficiencies.
- Published in:
- Haemophilia, 2023, v. 29, n. 1, p. 199, doi. 10.1111/hae.14678
- By:
- Publication type:
- Article
Prophylaxis use of clotting factor replacement products in people with non‐severe haemophilia: A review of the literature.
- Published in:
- Haemophilia, 2023, v. 29, n. 1, p. 33, doi. 10.1111/hae.14676
- By:
- Publication type:
- Article
Applicability of the European Society of Cardiology Guidelines on the management of acute coronary syndromes to older people with haemophilia A – A modified Delphi consensus by the ADVANCE Working Group.
- Published in:
- Haemophilia, 2023, v. 29, n. 1, p. 21, doi. 10.1111/hae.14674
- By:
- Publication type:
- Article
Association of factor expression levels with annual bleeding rate in people with haemophilia B.
- Published in:
- Haemophilia, 2023, v. 29, n. 1, p. 115, doi. 10.1111/hae.14675
- By:
- Publication type:
- Article
Theory of change and strategic priorities of the world federation of haemophilia.
- Published in:
- Haemophilia, 2023, v. 29, n. 1, p. 45, doi. 10.1111/hae.14673
- By:
- Publication type:
- Article
Accessibility and visibility of genetic testing for haemophilia across Europe: Where do we stand?
- Published in:
- Haemophilia, 2023, v. 29, n. 1, p. 256, doi. 10.1111/hae.14672
- By:
- Publication type:
- Article
Patients with von Willebrand disease in China: Results of an online survey.
- Published in:
- Haemophilia, 2023, v. 29, n. 1, p. 230, doi. 10.1111/hae.14671
- By:
- Publication type:
- Article
Methods for anti‐factor VIII antibody levels in haemophilia A patients – validation of a multiplex immunoassay and comparability with assays measuring non‐neutralising and neutralising antibodies (inhibitors).
- Published in:
- Haemophilia, 2023, v. 29, n. 1, p. 336, doi. 10.1111/hae.14669
- By:
- Publication type:
- Article
Liver‐related complications before and after successful treatment of chronic hepatitis C virus infection in people with inherited bleeding disorders.
- Published in:
- Haemophilia, 2023, v. 29, n. 1, p. 106, doi. 10.1111/hae.14668
- By:
- Publication type:
- Article
Peri‐operative hemostatic management of tooth extraction in patients with hemophilia A, with and without inhibitors, receiving emicizumab prophylaxis.
- Published in:
- Haemophilia, 2023, v. 29, n. 1, p. 172, doi. 10.1111/hae.14667
- By:
- Publication type:
- Article
Factor IX inhibitors in haemophilia B: A report of National Haemophilia Registry in China.
- Published in:
- Haemophilia, 2023, v. 29, n. 1, p. 123, doi. 10.1111/hae.14665
- By:
- Publication type:
- Article
Reinvestigation of unidentified causative variants in FXI‐deficient patients: Focus on gene segment deletions.
- Published in:
- Haemophilia, 2023, v. 29, n. 1, p. 248, doi. 10.1111/hae.14666
- By:
- Publication type:
- Article
Anti‐idiotype monoclonal antibodies against emicizumab enable accurate procoagulant and anticoagulant assays, irrespective of the test base, in the presence of emicizumab.
- Published in:
- Haemophilia, 2023, v. 29, n. 1, p. 329, doi. 10.1111/hae.14662
- By:
- Publication type:
- Article
Emicizumab for the treatment of acquired hemophilia A: Retrospective review of a single‐institution experience.
- Published in:
- Haemophilia, 2023, v. 29, n. 1, p. 84, doi. 10.1111/hae.14664
- By:
- Publication type:
- Article